Spravato® nasal spray is a groundbreaking therapy that can provide rapid relief from severe depression using a ketamine derivative called esketamine.
In 2019, Spravato was approved by the FDA to provide relief for those suffering from treatment-resistant depression (TRD).
To find out if Spravato is right for you, schedule a free consultation with our doctor.
If you’ve tried two or more antidepressant treatments without success, Spravato may be the solution you’ve been looking for.
Spravato works by targeting different chemicals in the brain than conventional antidepressants do.
Antidepressants increase levels of chemical messengers like dopamine and serotonin, which regulate mood. Spravato, on the other hand, increases a mood-enhancing neurotransmitter called glutamate, which in turn affects neuroplasticity, or the brain’s ability to form new neural pathways and “rewire.”
Spravato is administered twice a week for the first 4 weeks. These first 8 sessions are known as the induction phase.
Each session lasts 2 hours. Put on your eye mask, listen to music and just let go. You’ll be closely monitored by our physicians on site to ensure your safety and well-being.
After the induction phase, weekly treatments are recommended for 4 weeks, followed by maintenance sessions as needed. We create a personalized schedule together tailored to you.
If you are diagnosed with treatment-resistant depression and meet the following criteria, then insurance may cover your Spravato treatment if you have previously tried 2 antidepressants, without success.
We want to make things easy for you.
Our team reviews your insurance information to see if you are covered. If you’re eligible, we take care of the entire approval process. All you have to do is give us a call.
IV Ketamine and Spravato differ in delivery, session frequency and affordability. Both are clinically proven to help treat mental health conditions including treatment resistant depression.
9:am- 8:pm
9:am- 8:pm
9:am- 8:pm
9:am- 8:pm
9:am- 8:pm
9:am- 8:pm
9:am- 8:pm
Please note: The availability of treatment sessions may vary by office depending on our clinical team's schedule. Please reach out to us directly for the most up-to-date appointment times.
9:am- 8:pm
Please note: The availability of treatment sessions may vary by office depending on our clinical team's schedule. Please reach out to us directly for the most up-to-date appointment times.
If you take Spravato as prescribed and in a professional medical setting, it is safe to use. Patients with a history of uncontrolled hypertension, brain mass or bleed may not be appropriate candidates for ketamine treatment. If you are pregnant or breastfeeding, please consult with your physician.
Many patients report improvement in their symptoms within hours of their first session. The response varies by individual, but rapid relief is a key benefit of ketamine therapy, especially for those with treatment-resistant conditions. Studies show that 70% of people respond to the treatment and 52% of patients achieved full remission of their depression symptoms after four weeks of treatment.
The side effects of Spravato can include mild nausea, dizziness, feelings of dissociation, anxiety or increased blood pressure. These typically resolve shortly after the treatment session. Our medical team monitors patients closely to manage any side effects effectively.
The induction phase includes 8 treatments delivered over 4 weeks. Each Spravato treatment lasts two hours. Following induction, patients move into the optimization phase and come once a month, then transition to a maintenance phase tailored to individual needs.
When Spravato treatment is administered as prescribed in a controlled medical setting, the risk of addiction is very low. Keta Medical Center provides physician supervision and close monitoring during each session to ensure safe use.
If you have a diagnosis of treatment‑resistant depression and have previously tried two or more antidepressant treatments, you may be eligible for Spravato. Keta Medical Center will review your treatment history during a consultation and verify insurance coverage to confirm eligibility and next steps.
No, Spravato requires administration under direct medical supervision in a certified therapy center as mandated by the FDA. Patients are monitored for potential side effects such as increased blood pressure and require an observation period after dosing. Keta Medical Center provides on‑site physician and nursing oversight throughout the session to ensure safety and well‑being.
Our medical director will conduct a consultation and medical screening to review your diagnosis, prior treatment history, current medications, and overall health, and recommend the most appropriate option. Insurance coverage may also play a role in determining the best path forward. Spravato is covered by most major insurance plans, and our team handles all verification, paperwork, and prior authorizations on your behalf. IV ketamine infusions are not typically covered by insurance, though flexible payment options are available.
We know life is busy, so at Keta Medical Center, we offer evening and weekend hours to fit your schedule. Our friendly administrative staff is always available to answer your questions and address any concerns. Our goal is to support you as you embark on your mental health journey with ketamine therapy.
